Vitamin E and Pentoxifylline in Treating Women With Lymphedema After Radiation Therapy for Breast Cancer
Double-Blind, Placebo-Controlled, Randomised Trial Of Alpha-Tocopherol And Oxpentifylline In Patients With Radiation Fibrosis
3 other identifiers
interventional
N/A
1 country
1
Brief Summary
RATIONALE: Vitamin E and pentoxifylline may be effective in decreasing lymphedema in women who have received radiation therapy for breast cancer. PURPOSE: Randomized phase II trial to determine the effectiveness of combining vitamin E and pentoxifylline in treating women who have lymphedema after receiving radiation therapy for breast cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2000
CompletedFirst Submitted
Initial submission to the registry
August 10, 2001
CompletedFirst Posted
Study publicly available on registry
February 4, 2004
CompletedNovember 6, 2013
May 1, 2007
August 10, 2001
November 5, 2013
Conditions
Keywords
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (1)
Royal Marsden Hospital
Sutton, England, SM2 5PT, United Kingdom
Related Publications (1)
Gothard L, Cornes P, Earl J, Hall E, MacLaren J, Mortimer P, Peacock J, Peckitt C, Woods M, Yarnold J. Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer. Radiother Oncol. 2004 Nov;73(2):133-9. doi: 10.1016/j.radonc.2004.09.013.
PMID: 15542159RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
John R. Yarnold, MD, FRCR
Royal Marsden NHS Foundation Trust
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Purpose
- SUPPORTIVE CARE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 10, 2001
First Posted
February 4, 2004
Study Start
January 1, 2000
Last Updated
November 6, 2013
Record last verified: 2007-05